KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xenon Pharmaceuticals (XENE) Gross Profit: 2013-2025

Historic Gross Profit for Xenon Pharmaceuticals (XENE) over the last 9 years, with Mar 2025 value amounting to $7.5 million.

  • Xenon Pharmaceuticals' Gross Profit was N/A to $7.5 million in Q1 2025 from the same period last year, while for Mar 2025 it was $16.9 million, marking a year-over-year change of. This contributed to the annual value of $9.4 million for FY2022, which is 48.83% down from last year.
  • Xenon Pharmaceuticals' Gross Profit amounted to $7.5 million in Q1 2025, which was up 5,581.82% from $132,000 recorded in Q3 2022.
  • Xenon Pharmaceuticals' Gross Profit's 5-year high stood at $8.8 million during Q1 2022, with a 5-year trough of $132,000 in Q3 2022.
  • In the last 1 years, Xenon Pharmaceuticals' Gross Profit had a median value of $7.5 million in 2025 and averaged $7.5 million.
  • Over the last 5 years, Xenon Pharmaceuticals' Gross Profit had its largest YoY gain of 101.15% in 2022, and its largest YoY loss of 97.07% in 2022.
  • Xenon Pharmaceuticals' Gross Profit (Quarterly) stood at $3.7 million in 2021, then plummeted by 97.07% to $132,000 in 2022, then reached $7.5 million in 2025.
  • Its last three reported values are $7.5 million in Q1 2025, $132,000 for Q3 2022, and $536,000 during Q2 2022.